Elbow Replacement Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Elbow Replacement Market Report is Segmented by Product Type (Partial Elbow Replacement, Total Elbow Replacement), Implant Material (Titanium Alloys, Cobalt–chrome Alloys, Tantalum & Others), Fixation Technique (Cemented, Cement-Less), End User (Hospitals, and More), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Elbow Replacement Market Size and Share

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Compare market size and growth of Elbow Replacement Market with other markets in Healthcare Industry

Elbow Replacement Market Analysis by Mordor Intelligence

The Elbow Replacement Market size is estimated at USD 184.85 million in 2025, and is expected to reach USD 252.34 million by 2030, at a CAGR of 6.54% during the forecast period (2025-2030).

Escalating end-stage elbow arthritis cases, wider surgeon familiarity with total elbow arthroplasty, and steady improvements in 3D-printed, patient-matched implants anchor this expansion. Rapid gains in outpatient surgical infrastructure, coupled with favorable reimbursement adjustments for complex extremity procedures, further widen patient access. Linked-hinge prostheses are outperforming earlier designs on revision-free survival, while antimicrobial surface technologies cut deep infection risk and drive long-term implant success. The elbow replacement market also benefits from rising procedure volumes in Asia-Pacific as hospitals modernize orthopedic theaters and local manufacturers secure regulatory clearances.

Key Report Takeaways

  • By product type, total elbow replacement led with 68.17% revenue share in 2024; partial elbow replacement is advancing at a 6.80% CAGR through 2030. 
  • By implant material, cobalt-chrome alloys captured 51.59% of the elbow replacement market share in 2024; titanium alloys record the fastest growth at 7.13% CAGR to 2030. 
  • By fixation technique, cemented approaches maintained 63.22% dominance in 2024, while cement-less systems expand at an 8.03% CAGR through 2030. 
  • By end user, hospitals held 57.42% of the elbow replacement market size in 2024; orthopedic and specialty centers post the highest growth at 8.84% CAGR to 2030. 
  • By geography, North America accounted for 39.81% of 2024 revenues, whereas Asia-Pacific is set to climb at a 7.55% CAGR through 2030.

Segment Analysis

By Product Type: Total Replacement Remains the Benchmark

Total elbow replacement generated 68.17% of 2024 revenue, underlining its role as a comprehensive solution for severe articular destruction. This dominance reflects decades of outcome data showing median Mayo scores jumping from the low 40s to the mid-90s post-surgery. Partial systems, covering hemi-arthroplasty and radial head prostheses, are climbing at a 6.80% CAGR through 2030 as they better suit younger trauma patients. Surgeons increasingly reserve total systems for inflammatory or end-stage degenerative conditions while opting for bone-preserving partial options in complex fractures, expanding the elbow replacement market addressable base.

Clinical registries corroborate these trends, noting partial implants achieve 17% reoperation rates—acceptable given the elbow’s demanding biomechanics—when postoperative weight limits are respected. Both categories benefit from intraoperative 3D navigation that sharpens component alignment. In parallel, modular ulnar stems let surgeons upsize fixation when encountering osteoporotic canals, further reducing early loosening. This blend of versatility and evidence retention secures steady volume growth across both product lines within the elbow replacement market.

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Implant Material: Titanium’s Osseointegration Edge

Cobalt-chrome retained 51.59% share owing to its proven wear resistance, yet titanium alloys are notching a 7.13% CAGR. Threaded titanium stems boost cancellous purchase and reduce stress shielding, qualities that resonate with surgeons focused on long-term bone preservation. Novel porous tantalum sleeves and PEEK composites continue in niche roles but command interest for revision cases with compromised bone stock.

Laser-textured surfaces and hydroxyapatite coatings amplify titanium’s osteoconductivity, enabling earlier functional loading. Concurrently, antimicrobial film deposition targets periprosthetic infection, a pivotal failure mode. As these enhancements mature, material mix is likely to tilt incrementally toward titanium without displacing chrome-cobalt’s seat in high-demand applications. The elbow replacement market size for titanium-based systems is therefore expected to climb meaningfully yet progressively over the forecast horizon.

By Fixation Technique: Cement-Less Uptake Accelerates

Cemented fixation still accounts for 63.22% of implantations, valued for immediate stability, especially in osteopenic bone. However, cement-less techniques outpace at an 8.03% CAGR as porous architectures and press-fit stems foster biological integration. Cases employing cement-less humeral components paired with cemented ulnar stems illustrate a pragmatic hybrid pathway that eases future revision.

Ten-year survivorship exceeding 94% for cement-less partial knees has emboldened regulators to green-light similar concepts for the elbow. Surgeons appreciate shorter operative windows and avoidance of cement mantle complications. Consequently, the elbow replacement market share of fully biological fixation is forecast to widen primarily in urban centers handling higher volumes of younger, high-demand patients.

Elbow Replacement Market: Market Share by Fixation Technique
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By End User: Specialty Hubs Gain Momentum

Hospitals retained 57.42% revenue share in 2024, a function of critical-care backup and broad insurance acceptance. Specialized orthopedic centers, though smaller, are expanding at 8.84% CAGR by leveraging dedicated teams, fast-track pathways, and bundled-payment contracts. Patient satisfaction scores consistently run higher in these settings, fuelling positive word-of-mouth and surgeon alignment.

ASC-based programs are emerging where payer policy permits, bundling anesthesia, implant, and therapy in single-invoice models that streamline reimbursement. Manufacturers now partner directly with high-volume centers to field test next-gen elbows under real-world conditions, reinforcing the sector’s influence on device design and procurement.

Geography Analysis

North America preserved leadership with 39.81% of 2024 turnover, thanks to robust reimbursement frameworks and a dense network of fellowship-trained upper-extremity surgeons. Medicare fee stability and clearly defined CPT codes underpin steady procedural uptake. Europe follows, buoyed by stringent MDR standards that reassure clinicians of implant safety while still encouraging innovation through fast-track 3D printing approvals.

Asia-Pacific is the fastest riser, projected at 7.55% CAGR, as China, India, and South Korea broaden social insurance and cultivate domestic implant fabrication. National procurement drives lower unit prices, expanding hospital budgets for complex reconstructions. Latin America and the Middle East & Africa trail but show meaningful upside where urban private hospitals install advanced imaging and laminar-flow theaters. Collectively, these patterns support geographically diversified growth for the elbow replacement market.

Elbow Replacement Market CAGR (%), Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

Market concentration is moderate, with a handful of global orthopedic firms controlling the premium segment and regional specialists catering to value-tier demand. Enovis reinforced its extremities franchise through the EUR 800 million LimaCorporate acquisition in 2024, unlocking proprietary Trabecular Titanium 3D platforms. Stryker’s prior Wright Medical purchase delivered entry to a complementary trauma and biologics pipeline. Zimmer Biomet continues to integrate AI-enabled imaging after buying OrthoGrid, aiming to refine intraoperative alignment.

Strategic priorities center on additive manufacturing, antimicrobial surfaces, and robotics-assisted alignment. Cross-licensing between implant and software vendors accelerates development cycles, while hospital-aligned partnerships foster procedural standardization. Overall, technological differentiation and emerging-market penetration remain decisive fronts in the elbow replacement market competition.

Elbow Replacement Industry Leaders

  1. Johnson & Johnson

  2. Stryker Corporation

  3. Zimmer Biomet

  4. Smith & Nephew plc

  5. Enovis

  6. *Disclaimer: Major Players sorted in no particular order
Elbow.png
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • November 2024: Zimmer Biomet received FDA approval for the Oxford Cementless Partial Knee, the only cementless partial knee replacement implant in the U.S., demonstrating 94.1% implant survival at 10 years and superior performance compared to traditional cemented implants. This approval signals broader regulatory acceptance of cement-less fixation technologies that may extend to elbow replacement applications
  • August 2024: Stryker announced the launch of its Pangea Plating System, which received FDA clearance in late 2023, enhancing trauma care with variable-angle plating for various patient populations. The system features 20 anatomic plates and 13 utility plates designed for optimal implant fit and screw placement, supporting elbow fracture management and reconstruction procedures.
  • June 2024: Stryker announced its definitive agreement to acquire Artelon, Inc., a company specializing in soft tissue fixation products for orthopedic procedures. This acquisition aims to enhance Stryker's offerings in foot and ankle and sports medicine segments, with Artelon's technology designed to improve ligament and tendon reconstruction, potentially impacting elbow replacement procedures.
  • January 2024: Enovis Corporation completed its acquisition of LimaCorporate S.p.A. for EUR 800 million, creating a ~USD 1 billion reconstruction business with approximately 50% of revenues from fast-growing extremities markets, including elbow replacement products. The acquisition enhances Enovis' position in the global orthopedic reconstruction market and provides access to Lima's innovative 3D printed Trabecular Titanium implants.

Table of Contents for Elbow Replacement Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Arthritis
    • 4.2.2 Rapid Adoption of Linked‐Hinge Designs
    • 4.2.3 Technological Advances in 3-D Printed Implants
    • 4.2.4 Shift Toward Outpatient/ASC Settings
    • 4.2.5 Expanding Reimbursement in Emerging Markets
    • 4.2.6 Antimicrobial Coating Breakthroughs
  • 4.3 Market Restraints
    • 4.3.1 Availability of Alternatives (Arthroscopy, Fusion)
    • 4.3.2 High Procedure & Device Cost
    • 4.3.3 Post-Operative Complications and Implant Longevity
    • 4.3.4 Limited Availability of Specialized Surgeons
  • 4.4 Technological Outlook
  • 4.5 Porter’s Five Forces Analysis
    • 4.5.1 Threat of New Entrants
    • 4.5.2 Bargaining Power of Buyers
    • 4.5.3 Bargaining Power of Suppliers
    • 4.5.4 Threat of Substitutes
    • 4.5.5 Competitive Rivalry

5. Market Size & Growth Forecasts (Value in USD)

  • 5.1 By Product Type
    • 5.1.1 Partial Elbow Replacement
    • 5.1.2 Total Elbow Replacement
  • 5.2 By Implant Material
    • 5.2.1 Titanium Alloys
    • 5.2.2 Cobalt–Chrome Alloys
    • 5.2.3 Tantalum & Others
  • 5.3 By Fixation Technique
    • 5.3.1 Cemented
    • 5.3.2 Cement-less
  • 5.4 By End User
    • 5.4.1 Hospitals
    • 5.4.2 Orthopedic & Specialty Centers
    • 5.4.3 Ambulatory Surgical Centers
  • 5.5 By Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East & Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East & Africa
    • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
    • 6.3.1 Zimmer Biomet
    • 6.3.2 Stryker Corp.
    • 6.3.3 Smith & Nephew plc
    • 6.3.4 DJO Global / Enovis
    • 6.3.5 Johnson & Johnson (DePuy Synthes)
    • 6.3.6 Lima Corporate
    • 6.3.7 Corin Group
    • 6.3.8 Exactech
    • 6.3.9 Medacta Group
    • 6.3.10 Aesculap (B. Braun)
    • 6.3.11 Arthrex
    • 6.3.12 Evolutis
    • 6.3.13 Implantcast GmbH
    • 6.3.14 Acumed LLC
    • 6.3.15 United Orthopedic Corp.
    • 6.3.16 Peter Brehm GmbH
    • 6.3.17 Biotechni
    • 6.3.18 An-Trauma
    • 6.3.19 Stryker Corporation

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-Need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Elbow Replacement Market Report Scope

As per the scope of the report, In elbow replacement, the physician replaces the elbow with an artificial joint made from two implants that attach to the bones in the arm. A metal and plastic hinge joins the implants together. The Elbow Replacement Market is segmented by Product (Partial Elbow Replacement, and Total Elbow Replacement), End User (Hospitals, Orthopedic Centers, Others), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product Type Partial Elbow Replacement
Total Elbow Replacement
By Implant Material Titanium Alloys
Cobalt–Chrome Alloys
Tantalum & Others
By Fixation Technique Cemented
Cement-less
By End User Hospitals
Orthopedic & Specialty Centers
Ambulatory Surgical Centers
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa GCC
South Africa
Rest of Middle East & Africa
South America Brazil
Argentina
Rest of South America
By Product Type
Partial Elbow Replacement
Total Elbow Replacement
By Implant Material
Titanium Alloys
Cobalt–Chrome Alloys
Tantalum & Others
By Fixation Technique
Cemented
Cement-less
By End User
Hospitals
Orthopedic & Specialty Centers
Ambulatory Surgical Centers
By Geography
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa GCC
South Africa
Rest of Middle East & Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

What is the current size of the elbow replacement market?

The elbow replacement market size reached USD 184.85 million in 2025.

How fast is the market expected to grow?

It is projected to expand at a 6.54% CAGR, achieving USD 252.34 million by 2030.

Which product segment dominates the market?

Total elbow replacement accounts for 68.2% of 2024 revenue, maintaining clear leadership.

Why are titanium implants gaining popularity?

Titanium alloys promote superior bone integration and are growing at a 7.13% CAGR within the material mix.

Which region is showing the fastest growth?

Asia-Pacific is advancing at a 7.55% CAGR, driven by expanding healthcare coverage and rising surgical capacity.

How is outpatient surgery influencing the market?

Migration to ambulatory surgical centers lowers episode costs and accelerates procedure volumes, especially in North America and select European markets.

Page last updated on: June 26, 2025

Elbow Replacement Market Report Snapshots